<?xml version="1.0" encoding="UTF-8"?>
<record
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd"
    xmlns="http://www.loc.gov/MARC21/slim">

  <leader>01348nam a22002537a 4500</leader>
  <controlfield tag="005">20261015162356.0</controlfield>
  <controlfield tag="008">261015m20141992|||||||| |||| 00| 0 eng d</controlfield>
  <datafield tag="020" ind1=" " ind2=" ">
    <subfield code="a">9780123820303</subfield>
  </datafield>
  <datafield tag="040" ind1=" " ind2=" ">
    <subfield code="c">PK-LaUMT</subfield>
  </datafield>
  <datafield tag="082" ind1=" " ind2=" ">
    <subfield code="a">615.19</subfield>
    <subfield code="b">SIL-O</subfield>
  </datafield>
  <datafield tag="100" ind1="1" ind2=" ">
    <subfield code="a">Silverman, Richard B.</subfield>
    <subfield code="9">16517</subfield>
  </datafield>
  <datafield tag="245" ind1="1" ind2="4">
    <subfield code="a">The organic chemistry of drug design and drug action /</subfield>
    <subfield code="c">Richard B. Silverman and Mark W. Holladay</subfield>
  </datafield>
  <datafield tag="250" ind1=" " ind2=" ">
    <subfield code="a">3rd ed.</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="a">Amsterdam :</subfield>
    <subfield code="b">Elsevier,</subfield>
    <subfield code="c">2014</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
    <subfield code="a">xviii, 517 p.</subfield>
  </datafield>
  <datafield tag="500" ind1=" " ind2=" ">
    <subfield code="a">Index present</subfield>
  </datafield>
  <datafield tag="546" ind1=" " ind2=" ">
    <subfield code="a">"The Organic chemistry of drug design and drug action, Third edition, represents a unique approach to medicinal chemistry based on physical organic chemical principles and reaction mechanisms that rationalize drug action, which allows the reader to extrapolate those core principles and mechanisms to many related classes of drug molecules. This new edition reflects significant changes in the process of drug design over the last decade. It preserves the successful approach of the previous editions while including significant changes in format and coverage."--Publisher's description</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2=" ">
    <subfield code="a">Pharmaceutical chemistry</subfield>
    <subfield code="9">1301</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2=" ">
    <subfield code="a">Bioorganic chemistry</subfield>
    <subfield code="9">16518</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2=" ">
    <subfield code="a">Molecular pharmacology</subfield>
    <subfield code="9">16519</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2=" ">
    <subfield code="a">Drugs-Design</subfield>
    <subfield code="9">16520</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a">Holladay, Mark W.</subfield>
    <subfield code="9">16521</subfield>
  </datafield>
  <datafield tag="942" ind1=" " ind2=" ">
    <subfield code="c">BK</subfield>
  </datafield>
  <datafield tag="999" ind1=" " ind2=" ">
    <subfield code="c">143427</subfield>
    <subfield code="d">143427</subfield>
  </datafield>
  <datafield tag="952" ind1=" " ind2=" ">
    <subfield code="0">0</subfield>
    <subfield code="1">0</subfield>
    <subfield code="4">0</subfield>
    <subfield code="7">0</subfield>
    <subfield code="a">HSC</subfield>
    <subfield code="b">HSC</subfield>
    <subfield code="d">2026-10-15</subfield>
    <subfield code="l">0</subfield>
    <subfield code="o">615.19 SIL-O</subfield>
    <subfield code="p">154498</subfield>
    <subfield code="r">2026-10-15 16:24:06</subfield>
    <subfield code="w">2026-10-15</subfield>
    <subfield code="y">BK</subfield>
  </datafield>
</record>
